Fonte: Advances in therapy. Unidade: FM
Assuntos: ENVELHECIMENTO, AGREGAÇÃO PLAQUETÁRIA, ESTUDOS PROSPECTIVOS, MEIA IDADE
ABNT
ARANTES, Flavia B. B et al. Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: a Prospective Interventional Trial. Advances in therapy, v. 37, n. 1, p. 420-430, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12325-019-01153-8. Acesso em: 03 nov. 2024.APA
Arantes, F. B. B., Menezes, F. R., Franci, A., Barbosa, C. J. D. G., Dalcoquio, T. F., Nakashima, C. A. K., et al. (2020). Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: a Prospective Interventional Trial. Advances in therapy, 37( 1), 420-430. doi:10.1007/s12325-019-01153-8NLM
Arantes FBB, Menezes FR, Franci A, Barbosa CJDG, Dalcoquio TF, Nakashima CAK, Baracioli LM, Ramires JAF, Kalil Filho R, Nicolau JC. Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: a Prospective Interventional Trial [Internet]. Advances in therapy. 2020 ; 37( 1): 420-430.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s12325-019-01153-8Vancouver
Arantes FBB, Menezes FR, Franci A, Barbosa CJDG, Dalcoquio TF, Nakashima CAK, Baracioli LM, Ramires JAF, Kalil Filho R, Nicolau JC. Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: a Prospective Interventional Trial [Internet]. Advances in therapy. 2020 ; 37( 1): 420-430.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s12325-019-01153-8